Key facts
- This page summarizes Po Yu (jeff) Chen's Form 4 filing for Alto Neuroscience, Inc. (ANRO).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 05 Feb 2024, 16:43.
Po Yu (jeff) Chen - 01 Feb 2024 Form 4 Insider Report for Alto Neuroscience, Inc. (ANRO)
- Reporting relationship
- Director
- Issuer ticker
- ANRO
- Reported as of
- 01 Feb 2024
- Net transaction value
- +$18,301
- SEC form
- 4
- Accepted by SEC
- 05 Feb 2024, 16:43:55 UTC
- Next SEC filing
- 07 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Erin R. McQuade, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Po Yu (jeff) Chen filed Form 4 for Alto Neuroscience, Inc. (ANRO) on 05 Feb 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$18,301.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ANRO
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +30,574
- Change %
- Price
- $0.000000
- Shares after
- 30,574
- Date
- 01 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,574
- Exercise price
- $16.00
- Footnotes
- F1
ANRO
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $18,301
- Shares
- +1,540
- Change %
- Price
- $11.88*
- Shares after
- 1,540
- Date
- 01 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,540
- Exercise price
- $16.00
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The shares underlying the option shall vest in 36 equal monthly installments commencing on March 1, 2024, subject to the Reporting Person's continuous service through each vesting date.
Footnote F2
280 shares underlying the option shall vest on March 31, 2024, and 420 shares underlying the option shall vest on each of June 30, 2024, September 30, 2024 and December 31, 2024, subject to the Reporting Person's continuous service through each such vesting date.
Footnote F3
This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $18,333.50.